Enanta Pharmaceuticals | Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
AbbVie USD 5.63B 838M 2025-09
Amgen USD 9.13B 316M 2025-12
Anika Therapeutics USD 57.99M 4.82M 2025-09
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
BioCryst Pharmaceuticals USD 84.08M 3.95M 2025-09
Biogen USD 3.01B 854.3M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Enanta Pharmaceuticals USD 32.3M 12.51M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Halozyme Therapeutics USD 419.66M 357.8M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Immunic USD 35.13M 20.18M 2025-09
Incyte USD 3.58B 650.78M 2025-12
Insmed USD 334.76M 949.56M 2025-09
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
J&J USD 18.23B 10.35B 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Ligand Pharmaceuticals USD 664.52M 596.85M 2025-09
Merck USD 18.17B 10.16B 2025-09
Neurocrine Biosciences USD 340.2M 76.2M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Novavax USD 268.02M 14.28M 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 672.62M 344.77M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
Vertex Pharmaceuticals USD 6.29B 95.8M 2025-09


Enanta Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.